James I Koenig
Overview
Explore the profile of James I Koenig including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
50
Citations
1821
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Flemming K, Kim H, Hage S, Mandrekar J, Kinkade S, Girard R, et al.
Stroke
. 2023 Dec;
55(1):22-30.
PMID: 38134268
Background: Cerebral cavernous malformation with symptomatic hemorrhage (SH) are targets for novel therapies. A multisite trial-readiness project (https://www.clinicaltrials.gov; Unique identifier: NCT03652181) aimed to identify clinical, imaging, and functional changes in...
2.
Hage S, Kinkade S, Girard R, Flemming K, Kim H, Torbey M, et al.
Stroke
. 2023 Dec;
55(1):31-39.
PMID: 38134265
Background: Quantitative susceptibility mapping (QSM) and dynamic contrast-enhanced quantitative perfusion (DCEQP) magnetic resonance imaging sequences assessing iron deposition and vascular permeability were previously correlated with new hemorrhage in cerebral cavernous...
3.
Lyden P, Diniz M, Bosetti F, Lamb J, Nagarkatti K, Rogatko A, et al.
Sci Transl Med
. 2023 Sep;
15(714):eadg8656.
PMID: 37729432
Human diseases may be modeled in animals to allow preclinical assessment of putative new clinical interventions. Recent, highly publicized failures of large clinical trials called into question the rigor, design,...
4.
Wright C, Bosetti F, Koenig J, Janis L
Stroke
. 2023 Jul;
54(8):e393-e394.
PMID: 37486989
No abstract available.
5.
Morais A, Locascio J, Sansing L, Lamb J, Nagarkatti K, Imai T, et al.
Stroke
. 2023 Jan;
54(2):620-631.
PMID: 36601951
The Stroke Preclinical Assessment Network (SPAN) is a multicenter preclinical trial platform using rodent models of transient focal cerebral ischemia to address translational failure in experimental stroke. In addition to...
6.
Lyden P, Bosetti F, Diniz M, Rogatko A, Koenig J, Lamb J, et al.
Stroke
. 2022 Mar;
53(5):1802-1812.
PMID: 35354299
Cerebral ischemia and reperfusion initiate cellular events in brain that lead to neurological disability. Investigating these cellular events provides ample targets for developing new treatments. Despite considerable work, no such...
7.
Spilka M, Keller W, Buchanan R, Gold J, Koenig J, Strauss G
Acta Psychiatr Scand
. 2022 Mar;
145(5):494-506.
PMID: 35243618
Objective: Difficulties in social cognition are common in individuals with schizophrenia (SZ) and are not ameliorated by antipsychotic treatment. Intranasal oxytocin (OT) administration has been explored as a potential intervention...
8.
Bosetti F, Koenig J, Janis L, Wright C
Stroke
. 2021 Nov;
52(12):e842-e843.
PMID: 34807746
No abstract available.
9.
Kim H, Flemming K, Nelson J, Lui A, Majersik J, Cruz M, et al.
Stroke
. 2021 Sep;
52(12):3829-3838.
PMID: 34525838
Background And Purpose: Brain cavernous angiomas with symptomatic hemorrhage (CASH) have a high risk of neurological disability from recurrent bleeding. Systematic assessment of baseline features and multisite validation of novel...
10.
Girard R, Li Y, Stadnik A, Shenkar R, Hobson N, Romanos S, et al.
Neurosurgery
. 2021 Jan;
88(3):686-697.
PMID: 33469662
Background: Cerebral cavernous angioma (CA) is a capillary microangiopathy predisposing more than a million Americans to premature risk of brain hemorrhage. CA with recent symptomatic hemorrhage (SH), most likely to...